STOCK TITAN

TARS (NASDAQ: TARS) insider filings show proposed sale and recent dispositions

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TARS filed a Form 144 reporting proposed sales tied to recently vested restricted common stock and recent dispositions by an insider. The filing lists 11,964 shares associated with restricted stock vesting on 03/18/2026 and shows prior sales by Bobak Azamian of 10,972 shares on 03/17/2026 and 11,667 shares on 03/18/2026, with dollar amounts shown alongside each sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TARS Form 144 disclose about the shares to be sold?

The filing discloses 11,964 common shares tied to restricted stock vesting on 03/18/2026. It identifies the transaction type as compensation (restricted stock vesting) and lists a broker/dealer record for the position.

Who reported recent sales in the TARS Form 144 and how many shares were sold?

The filing shows recent dispositions by Bobak Azamian: 10,972 shares sold on 03/17/2026 and 11,667 shares sold on 03/18/2026, with corresponding dollar figures reported alongside each trade.

Are the dollar amounts for the reported sales included in the TARS Form 144?

Yes. The filing lists sale proceeds alongside each disposition: $761,618.09 for the 10,972-share sale and $801,637.24 for the 11,667-share sale, as reported in the transaction lines.

Was a broker or brokerage account identified in the TARS Form 144?

The filing references Fidelity Brokerage Services LLC with an address and includes a record of 11,964 shares (listed near the broker line) and a NASDAQ designation, indicating the broker/dealer handling the shares.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

View TARS Stock Overview

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

2.93B
40.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
IRVINE